Skip to main content

Table 1 Patient baseline characteristics

From: Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device

 

All patients

Pt. with eGFR≥45

Pt. with eGFR< 45

p

n

189

116

73

 

Male sex, n (%)

116 (61.4)

74 (63.8)

42 (57.5)

0.18

Mean age (years)

73.4 ± 7.9

72.1 ± 8.0

75.9 ± 6.7

0.10

BMI (kg/m2)

29.3 ± 5.4

28.94 ± 5.5

29.28 ± 5.2

0.83

BSA (m2)

1.96 ± 0.23

1.96 ± 0.20

1.95 ± 0.24

0.58

CHA2DS2-VASc score

3.88 ± 1.6

3.40 ± 1.57

4.50 ± 1.42

< 0.01

HAS-BLED – Score

3.35 ± 1.0

3.13 ± 0.9

3.65 ± 1.0

< 0.01

Arterial hypertension, n (%)

164 (86.8)

98 (84.5)

66 (90.4)

0.32

Diabetes mellitus, n (%)

85 (45.0)

40 (34.5)

45 (61.6)

< 0.01

Hyperlipidaemia, n (%)

94 (49.7)

56 (48.3)

38 (52.1)

0.42

Smoking status

 non-smoker, n (%)

138 (73.0)

81 (69.8)

57 (78.1)

0.12

 smoker, n (%)

25 (13.2)

15 (12.9)

10 (13.7)

0.70

 stopped smoking, n (%)

26 (13.8)

20 (17.2)

6 (8.2)

0.10

Atrial fibrillation

 paroxysmal, n (%)

75 (39.7)

48 (41.4)

27 (37.0)

0.33

 pers./perm., n (%)

114 (60.3)

68 (58.6)

46 (63.0)

 

Previous stroke / TIA, n (%)

33 (17.2)

21 (17.5)

12 (16.4)

0.80